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Abstract
St. Louis encephalitis virus (SLEV, Flavivirus, Flaviviridae) is an emerging mosquito-borne pathogen in South America, with
human SLEV encephalitis cases reported in Argentina and Brazil. Genotype III strains of SLEV were isolated from Culex
quinquefasciatus mosquitoes in Cordoba, Argentina in 2005, during the largest SLEV outbreak ever reported in South
America. The present study tested the hypothesis that the recent, epidemic SLEV strain exhibits greater virulence in birds as
compared with a non-epidemic genotype III strain isolated from mosquitoes in Santa Fe Province 27 years earlier. The
observed differences in infection parameters between adult House sparrows (Passer domesticus) that were needle-
inoculated with either the epidemic or historic SLEV strain were not statistically significant. However, only the House
sparrows that were infected with the epidemic strain achieved infectious-level viremia titers sufficient to infect Cx. spp.
mosquitoes vectors. Furthermore, the vertebrate reservoir competence index values indicated an approximately 3-fold
increase in amplification potential of House sparrows infected with the epidemic strain when pre-existing flavivirus-reactive
antibodies were present, suggesting the possibility that antibody-dependent enhancement may increase the risk of avian-
amplified transmission of SLEV in South America.
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Introduction
The geographic distribution of St. Louis encephalitis virus
(SLEV, Flavivirus, Flaviviridae) encompasses tropical, sub-tropical
and much of the temperate-tropical zones of the Western
Hemisphere and therefore, most of the populated land masses of
North and South America [1]. In the United States of America
(USA), this virus is known to be naturally maintained by
transmission cycles between several Culex (Cx.) mosquito species
and a variety of bird species, including the House sparrow (Passer
domesticus) [2]. SLEV is an emerging arbovirus in South
America, with febrile illness and encephalitis cases reported in
Argentina in 2002 and 2005, and in Brazil in 2004 and 2006
[3–6].
In Argentina, SLEV reemerged in the central region (i.e.,
Co ´rdoba and Santa Fe Provinces) in 2002, when two cases of
encephalitis and three fever cases were reported in humans
(Morales MA and Enria D, unpublished data) [5]. In 2005, 47
laboratory-confirmed clinical cases of SLEV infection, including
nine fatalities, were reported from Co ´rdoba Province [7]. Two
genotype III SLEV isolates were obtained from Cx. quinquefasciatus
mosquitoes during this outbreak [4]. Genotype III SLEV was
previously isolated from mosquitoes collected in Santa Fe Province
27 years earlier with no human encephalitis cases reported [8].
The cause of the 2005 outbreak remains unknown, but may have
derived from virological factors, changes in populations of vectors
and/or avian amplifying hosts, and/or environmental conditions
[9–11]. These were the first reported outbreaks of SLEV-induced
encephalitis in South America. By March 2010, the Health
Ministry of Buenos Aires Province reported a total of five
confirmed and five probable human cases of SLEV [12]. In
Brazil, SLEV was identified as the etiologic agent of a small
meningoencephalitis outbreak among humans in Sao Paulo State
in 2006 [3].
We propose that the recently isolated genotype III strain has
pathogenic properties in an avian model, and more specifically,
House sparrows. These properties presumably favor epidemic
activity relative to the historical genotype III strain that was
thought to be enzootic. To test this hypothesis, we evaluated the
viremogenic and pathogenic capacities of both recent and historic
genotype III isolates from Co ´rdoba in House sparrows. In
addition, we evaluated cross-protection conferred by heterologous
flavivirus-neutralizing antibodies in a small number of SLEV-
challenged House sparrows.
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Birds and animal care
House sparrows (hatch-year or older; i.e., adults) were captured
in mist nets during January 2007 in Larimer County, Colorado
and housed in commercial cages (Safeguard, Inc., New Holland,
PA). Mixed bird seed and water were provided ad libitum. The
maintenance and care of experimental animals in this study
complied with institutional guidelines and the National Institutes
of Health guidelines for the humane use of laboratory animals. All
animal use was conducted at Colorado State University under
approval from the Institutional Animal Care and Use Committee
(approval 09-137A).
Virus strains
The CbaAr-4005 (epidemic) and 79V-2533 (non-epidemic)
SLEV strains were isolated from pools of adult female Cx.
quinquefasciatus collected in 2005 in Co ´rdoba Province and Cx.
(Culex) spp. collected in 1978 in Santa Fe Province, Argentina,
respectively [4,8]. The CbaAr-4005 strain had previously been
passaged four times and the 79V-2533 strain two times, and all
passages were in African Green monkey kidney (Vero) cells.
Inoculation of birds and sample collection
House sparrows were needle-inoculated subcutaneously over
the breast with 3,000 plaque-forming units (PFU) with one of the
two SLEV strains (or mock BA-1 inoculation for the negative
control group) in 0.1 mL (milliliter) of BA-1 diluent (Hanks M-199
salts, 0.05 M Tris, pH 7.6, 1% bovine serum albumin, 0.35 g/L of
sodium bicarbonate, 100 units/mL of penicillin, 100 mg/mL of
streptomycin, 1 mg/mL of Fungizone). Seven seronegative birds
were inoculated with 79V-2533 (Group A), 8 seronegative (Group
B) and 4 flavivirus-seropositive birds (Group C) were inoculated
with CbaAr-4005, and 10 birds (Group D) were mock-inoculated
with BA-1 to serve as a non-inoculated, morbidity/mortality
control group. Following inoculation, birds were monitored for
clinical signs (e.g., lethargy, fluffed feathers, decreased activity, and
emaciation) every 12 h. From 1–7 days post-inoculation (DPI),
0.1 mL of blood was collected by jugular venipuncture from each
bird (including controls) and diluted in 0.45 mL of BA-1 in 2-mL
cryovials. The samples were centrifuged for separation of serum
(diluted approximately 1:10) and stored at 280uC until assayed for
infectious viral particles.
Virus assays
The detection and titration of viruses in blood samples was
performed using a double-overlay Vero cell plaque assay [13]. The
second overlay contained neutral red dye and was added on 5
DPI; plaques were counted on 6 and 7 DPI. Each sample was
titrated in duplicate using serial 10-fold dilutions in BA-1 diluent.
The detection threshold for SLEV in serum was 10
1.7 PFU/mL.
Serology
Pre-inoculation status for flavivirus-reactive antibodies was
determined by blocking ELISA (enzyme-linked immunosorbent
assay) using the flavivirus group-reactive monoclonal antibody
6B6C-1 and sonicated suspension of CbaAr-4005 antigen [14].
Serum samples collected between 10–14 DPI were assayed using
the plaque reduction neutralization test (PRNT) using CbaAr-
4005 on Vero cell monolayer prepared in six-well cell culture
plates (Costar Inc, Cambridge, MA) [13]. Between 10 and 14 DPI,
all surviving House sparrows were bled (0.6 mL) and whole blood
was placed in Microtainer serum separator tubes (Becton
Dickinson, Franklin Lakes, NJ), centrifuged for separation of
serum, stored at 220uC, and heat inactivated at 56uC for 30 min
prior to testing. Serum samples were diluted 1:10 in BA-1 for
antibody screening, and serial 2-fold dilutions in duplicate were
used to determine reciprocal endpoint 80% SLEV antibody titers
(PRNT80). Because West Nile virus (WNV) is endemic in
Colorado, flavivirus-reactive antibodies were presumed to be due
to previous infection with WNV, which is commonly detected in
local House sparrows in northern Colorado (N. Komar,
unpublished data).
Mathematical calculations
Values for vertebrate reservoir competence index (C) were
calculated according to the formula:
C~(s)(i)(d)
where s is susceptibility to infection (a proportion of viremic birds),
i is the extrapolated mean daily infectiousness (the proportion of
feeding Cx. quinquefasciatus that are expected to become infected
after a viremic blood meal and surviving the extrinsic incubation
period; [i=0.5475*log viremia (PFU/ml) – 1.6526], and d is mean
duration of infectious viremia (in days) [15]. C indicates the
relative inherent potential for a vertebrate host to amplify a
pathogen to sufficient levels to infect vectors. Infectiousness was
extrapolated using data published by Mitchell et al. on oral
infectivity of Cx. quinquefasciatus for 78V-6507 SLEV Argentinean
strain. These data indicated an approximate threshold of
10
3.02 PFU/mL for infectious viremia titers [16].
Data analyses
Non-SLEV immune sparrows that were inoculated were
included in the analyses if they had evidence of infection (i.e.,
detectable SLEV-viremia between 1–7 DPI and/or seroconverted
by 10–14 DPI). Flavivirus-seropositive birds that were inoculated
Author Summary
St. Louis encephalitis virus (SLEV, Flavivirus, Flaviviridae)i s
an emerging arbovirus in South America, with human SLEV
encephalitis cases reported in Argentina and Brazil.
Genotype III strains of SLEV were isolated from mosquitoes
during the largest SLEV outbreak ever reported in South
America (Co ´rdoba, Argentina, 2005). These strains are
related to a non-epidemic genotype III SLEV strain isolated
in 1979 in Santa Fe Province, Argentina. There is currently
no clear explanation for the reemergence of SLEV in
Argentina. This study tested the hypothesis that the
epidemic strain exhibited greater virulence compared to
a non-epidemic genotype III strain in an avian model, the
House sparrow (Passer domesticus). House sparrows were
susceptible to infection with Argentinean SLEV strains;
however, the proportion of birds that became detectably
viremic was low for both strains. Although no significant
difference was detected between both strains, House
sparrows inoculated with epidemic strain developed
higher and longer viremias than those inoculated with
non-epidemic strain. The virus amplification role of House
sparrows was apparently enhanced when they had
previous flavivirus immunity. The evolutionary/introduc-
tion process of a more viremogenic SLEV strain and the
immunological interactions among antigenically-related
flaviviruses will undoubtedly affect the continued reemer-
gence of SLEV in Argentina.
Non-Epidemic and Epidemic SLEV Strains Comparison
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between 1–7 DPI. To compare susceptibility to infection and
mortality among experimental groups, Fisher’s exact test was used.
Mean durations of viremia and log-transformed mean peak
viremia measures were compared using a Poisson generalized
linear model and ANOVA, respectively, with significance
threshold a=0.05. Individuals were considered immune if they
had detectable anti-SLEV antibodies (PRNT80$10). Individuals
were considered refractory (i.e., not susceptible) to infection if they
did not show evidence of infection either by detectable viremia
titers and/or seroconversion.
Results
Four of seven House sparrows inoculated with 79V-2533
(Group A) had evidence of infection and were therefore included
in the mathematical analyses. Two had detectable viremia (mean
peak titer 10
3.1 PFU/mL serum, mean duration 1.5 days; Table 1)
and two were refractory to infection. Six of eight House sparrows
inoculated with CbaAr-4005 (Group B) were similarly included in
the analyses. Four of these birds had detectable viremia (mean
peak titer 10
5.3 PFU/mL serum, mean duration 2.75 days) and
two were refractory. Two of four anti-flavivirus antibody positive
birds that had been inoculated with CbaAr-4005 (Group C) were
also included in the analyses; these two birds developed detectable
viremia (mean peak titer was $10
7.1 PFU/mL serum, mean
duration $3.5 days (Table 1). The uncertainty in the upper limit
of the means for Group C is due to the peak viremia being in one
of House sparrows occurring on the last day of sampling (i.e., 7
DPI; Figure 1).
Mortality was observed in all four of the study groups, including
the non-inoculated control group. Through 7 DPI, mortality
occurred in 3 of 7 (Group A), 4 of 8 (Group B), 2 of 4 (Group C),
and 3 of 10 (Control Group) birds in the four groups. The rates did
not differ significantly among any of the groups (P.0.5).
Infection parameters (i.e., susceptibility to infection, mean
duration of viremia, and mean peak viremia titers) were compared
between House sparrows in Groups A and B, A and C, and B and
C. Sample sizes were insufficient to detect statistically significant
differences in any of these pair-wise comparisons. However,
considering that a threshold viremia titer for infection of vector
mosquitoes with the 79V-2533 SLEV strain could be estimated
from published data, and that the viremia titers observed in the
experimental groups appeared to be skewed in relation to this
threshold, we used these data to assess the biological significance of
the data. A rough estimate of the relative reservoir competence of
House sparrows in each experimental group indicated that adult
House sparrows were not competent amplifying hosts for the non-
epidemic SLEV strain (Group A). On the other hand, House
sparrows inoculated with the epidemic SLEV strain (Group B)
were theoretically able to produce 10 times more infectious
mosquitoes than those inoculated with the non-epidemic strain
(Table 2). House sparrows with prior flavivirus infection (Group C)
would infect three mosquitoes for every one mosquito infected by
flavivirus-naı ¨ve House sparrows (Group B) inoculated with the
epidemic SLEV strain (CbaAr-4005) (Table 2).
Discussion
Variation in biological characteristics (i.e., viremia profiles,
neuroinvasiveness, virulence, and pathogenicity) among SLEV
strains has been previously described [17,18,19]. Bowen et al. [18]
compared infection parameters for 44 strains of SLEV, including
14 from South America, in adult and juvenile House sparrows,
and found that strains could be categorized as low, intermediate,
or high viremogenic capacity [18]. In the present study, these same
infection parameters in adult House sparrows were compared for a
non-epidemic strain (presumably not pathogenic in humans) from
Argentina and a novel, epidemic strain isolated during the first
SLEV outbreak ever recognized in South America. The two
strains were isolated from the same subtropical region of northern
Argentina, but 27 years apart. The recently discovered strain
(CbaAr-4005) is associated with an outbreak of human enceph-
alitis resulting in nine fatalities in Co ´rdoba, Argentina. Despite
alignment of the genomes of these two strains within the same
genotype, the epidemic strain appears to be more viremogenic
than the non-epidemic strain in our model avian host. Compar-
ison of the complete genome sequences of the two strains revealed
an amino acid difference at position 249 in the NS3 protein. This
is the same position as described for bird-virulent strains of WNV
(T249P) [20].
Low or undetectable viremia titers among House sparrows in
the present study may have lessened the likelihood of detection of
statistically significant differences. The sample sizes were similar to
Table 1. Viremia and neutralizing antibody titer in House















2201 A - - na 0 nd{ UNK
2262 A - - na 0 nd{ UNK
2267 A 2.0 2.8 2.460.38 2 nd{ Inf
2269 A - - na 0 N Ninf
2270 A - - na 0 N Ninf
2272 A - - na 0 nd{ UNK
2273 A 3.3 3.3 na 1 nd{ Inf
2268 B 3.0 3.0 na 1 nd{ Inf
2275 B - - na 0 N NInf
2278 B - - na 0 N NInf
2279 B - - na 0 nd{ UNK
2281 B 2.0 3.0 2.860.24 4 20 Inf
2282 B 3.0 4.0 3.760.77 3 20 Inf
2283 B - - na 0 nd{ UNK
2287 B 4.0 6.0 5.060.11 2 40 Inf
2264 C - - na 0 nd{ UNK
2274 C 1.7 6.3 3.3 4 320 Inf
2276 C - - na 0 nd{ UNK
2288 C 3.3 7.6 5.5 3 nd{ Inf
aViremia titer expressed as log10 of PFU/mL serum. Min=minimum,
Max=maximum.
bPlaque reduction neutralization assay against SLEV with an 80% endpoint
(PRNT80) criterion. DPI=day postinoculation, N=negative, nd{=no data
available, individual died before sample collection. Inf=infected, NInf=not
infected, UNK=insufficient data. StDev=standard deviation.
cna=not applicable; neither mean nor standard deviation calculated due to lack
of data.
Group A: Naı ¨ve House sparrows inoculated with 79V-2533 SLEV strain (non-
epidemic), Group B: Naı ¨ve House sparrows inoculated with CbaAr-4005 SLEV
strain (epidemic) and Group C: Anti-flavivirus antibody positive House sparrows
inoculated with epidemic SLEV strain.
doi:10.1371/journal.pntd.0001177.t001
Non-Epidemic and Epidemic SLEV Strains Comparison
www.plosntds.org 3 May 2011 | Volume 5 | Issue 5 | e1177Figure 1. St. Louis encephalitis virus viremia detected in House sparrows inoculated with epidemic and non-epidemic strains. Group
A: 79V-2533/naı ¨ve, Group B: CbaAr-4005/naı ¨ve, Group C: CbaAr-4005/Flavivirus +. DPI: days post-inoculation.
doi:10.1371/journal.pntd.0001177.g001
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categories of viremogenic capacity failed to differentiate the two
Argentinean strains into either the high or low viremogenic
categories. However, using previously published data [16] for
vector competence of Cx. quinquefasciatus mosquitoes, data obtained
in the present study indicated that adult House sparrows infected
with the non-epidemic strain were incompetent amplifiers of
SLEV. House sparrows inoculated with the epidemic strain were
theoretically competent, based on a biologically significant
difference in the observed data for the two strains.
Viremia profiles varied among individuals, including among
those inoculated with the same SLEV strain. Intrinsic avian factors
such as genetics, age, and immunocompetence are likely to
variably-affect host responses to infection. The inverse effect of age
over resulting viremia profiles after arbovirus infection (i.e., older
individuals develop lower viremia titers than younger individuals)
has been well documented [18,21,22,23]. Although all House
sparrows in the present study were considered adults, we could not
further specify age beyond .1 year of age, so that actual ages may
have varied widely and therefore influenced viremic responses. In
addition, while we observed no visible health effects in these birds
during the pre-inoculation period, underlying health conditions
may also have affected their responses to infection. In addition,
previous studies have identified a specific gene (i.e., the Oas1b
gene; 29-59 oligoadenylate synthetases) as a determining factor for
resistance to infection in animals (i.e., humans, mice, chickens and
horses) [24,25,26]. Genetic variability in this gene and possibly
others among inoculated House sparrows in this study could have
also caused differences in responses to infection.
Mortality was observed in each of the four study groups, one of
which was the non-inoculated control group. No statistical
difference was detected in mortality among groups. Therefore,
we believe that the observed mortality was attributable to
captivity, handling stress, and possibly the aforementioned factors,
and not attributable to SLEV infection. Further, SLEV is not
historically believed to cause morbidity and mortality in birds
either experimentally or naturally infected [2,22,27,28].
The relatively small proportion of House sparrows with
detectable viremia titers, which were generally low, could indicate
co-adaptation of South American SLEV strains among the
resident avifauna. House sparrows have a broad geographic range
and are considered the main amplifying host of SLEV in south and
central USA, and House finches (Carpodacus mexicanus) the main
host for SLEV strains in the western coast of the USA (e.g.,
California) [2]. Argentinean SLEV strains are not well amplified
by resident House sparrows in Argentina. [LA Diaz, unpublished
data] However, Picui ground doves (Columbina picui) and Eared
doves (Zenaida auriculata) are amplifying hosts for SLEV strains in
Argentina [Diaz LA, unpublished data], further supporting the
idea that SLEV strains have become adapted to their respective
resident bird populations in both the USA and Argentina.
In the present study, House sparrows with evidence of previous
(i.e., natural) flavivirus infection that were subsequently inoculated
with SLEV strain CbaAr-4005 developed higher viremia titers of
longer duration than naı ¨ve House sparrows, as evidenced by a 3-
fold greater reservoir competence in the former. While this
assessment is based on a small number of available sparrows with
previous flavivirus immunity and more data are needed, it suggests
that SLEV activity may be enhanced by previous circulation of
WNV or other flaviviruses among avian host populations. Pre-
existing flavivirus-reactive antibodies in House sparrows (perhaps
homologous anti-SLEV or heterologous anti-WNV) may poten-
tiate subsequent SLEV infection, as indicated by the higher
resulting viremia titers in these birds following challenge. Ludwig
et al. reported a similar finding in a laboratory controlled
experimental SLEV infection of House sparrow chicks circulating
various levels of homologous maternal antibodies [29]. Viremia
titers of greater magnitude and duration were observed in nestling
House sparrows from SLEV-inoculated mothers versus nestlings
from naı ¨ve mothers. As maternal SLEV-neutralizing antibody
titers wane in nestling birds, antibody-mediated amplification of
serum virus titers may result following SLEV infection. Antibody-
dependent enhancement of Flavivirus infections is a well-known
phenomenon observed among humans with secondary dengue
virus infection [30]. However, House finches (Carpodacus mexicanus)
with pre-existing antibodies to WNV were protected from
experimental challenge with a North American strain of SLEV
[31].
With many closely-related flaviviruses circulating in South
America, the possibility of antibody-dependent enhancement of
SLEV infections in birds requires further investigation, especially if
an association with emergence of SLEV epidemic activity is to be
corroborated. In Brazil, for example, there are at least ten
circulating flaviviruses, including Bussuquara, Cacipacore ´, Den-
gue (serotypes 1 to 4), Igaupe, Ilheus, Rocı ´o, SLE, and yellow fever
viruses [32]. In addition, WNV and SLEV are now sympatric
throughout the Americas from southern Canada to central
Argentina, and co-circulation has been observed in some locations
with active SLEV surveillance programs such as Florida, Texas
and California [33,34]. WNV has been active in Argentina since at
least 2004, as indicated by detection of specific WNV-reactive
neutralizing antibodies in sera collected from a Rufous hornero
(Furnarius rufus), a resident passerine, sampled on 5 January 2005
[35]. The appearance of WNV in central Argentina shortly before
an unprecedented encephalitis epidemic caused by SLEV may not
have been a coincidence, but rather potentially the consequence of









b Comp. index (ci)
c R. comp. index
79V-2533/naı ¨ve (A) 0.5 0.15 1.5 0.11 1
CbaAr-4005/naı ¨ve (B) 0.7 0.58 2.8 1.14 10
AvsB
CbaAr-4005/Flavi+ (C)




as=mean ratio of viremic individuals/inoculated individuals.
bd=mean duration of viremia in days.
cCi (host competence index)=s * i * d. i=infectiousness for a given bird species.
dHouse sparrows with previous anti-flavivirus antibodies.
doi:10.1371/journal.pntd.0001177.t002
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our small study.
Currently, there is no definitive explanation for the reemer-
gence of SLEV in Argentina. Two possible explanations gain some
support from data in the present study. The first is the evolution or
introduction of a SLEV strain with increased viremogenicity. The
higher viremia titers generated by infections with the CbaAr-4005
strain in local amplifier species such as the Eared dove [36] will
theoretically lead to increased numbers of infected vectors.
Furthermore, this epidemic strain appears to broaden the number
of avian species that are likely to be competent amplifying hosts
relative to the non-epidemic 79V-2533 strain. The identification of
a limited number of specific amino acid substitutions between the
two genotype III strains used in the present study helps direct
future research to identify molecular virulence factors [37]. The
second possible explanation is that recent introduction of WNV
into the region has boosted the reservoir competence of local avian
reservoir hosts for SLEV through antibody-mediated enhance-
ment. WNV activity in the USA had a sobering impact on wild
bird populations, resulting in the deaths of millions of birds, while
SLEV does not cause avian mortality. However, since the
introduction of WNV to Argentina in 2004, there have been no
reports of associated avian mortalities. These explanations are not
mutually exclusive, and other factors may be involved. In order to
provide more support for our findings, further studies should focus
on the immunological interactions among antigenically-related
flaviviruses in birds and other potential amplifying hosts.
The possibility that this newly discovered epidemic SLEV strain
may spread within Argentina as well as to other regions of Central
and South America represents an important public health threat.
In early 2010, SLEV-associated encephalitis cases in humans were
reported in Buenos Aires Province [12]. During this outbreak,
molecular detections of SLEV were made. BLAST analyses
revealed that the nucleotide sequence of the 232 pb NS5
polymerase amplified fragment had 100% homology with that of
the epidemic CbaAr-4005 SLEV strain (GenBank accession #
FJ753286.1) (L. Valinotto, unpublished data), indicating an
epidemic association with a genotype III SLEV strain. Surveil-
lance for vector-borne pathogens remains an unattended civic
priority across the globe. In the absence of early detection through
environmental surveillance, clinicians should be on alert for
neurologic syndromes in human patients attributed to this novel
strain of SLEV.
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